|

Emapalumab Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Gamifant, Human anti-interferon gamma (IFNγ) monoclonal antibody

Pipeline

Phase 2: 2

Top Sponsors

  • Memorial Sloan Kettering Cancer Center1
  • Marcela V. Maus, M.D.,Ph.D.1

Indications

  • Cancer2
  • Hypocellular Marrow1
  • Cytopenia1
  • Large B-cell Lymphoma1
  • Primary Mediastinal Large B-Cell Lymphoma1

Boston, Massachusetts1 trial

Emapalumab Prevention of CAR-T Cell Associated Toxicities

Massachusetts General Hospital

Phase 2

New York, New York1 trial

A Study of Emapalumab for Pediatric Aplastic Anemia

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.